Sargramostim biosimilar (Emcure Pharmaceuticals)

沙格司亭生物类似药 (Emcure Pharmaceuticals)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSargramostim biosimilar (Emcure Pharmaceuticals)
Drug Alias Name沙莫司亭生物仿制药 (Emcure Pharmaceuticals)rhGM-CSF biosimilar (Emcure)沙格司亭生物仿制药 (Emcure Pharmaceuticals)沙拉莫司亭生物仿制药 (Emcure Pharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2013/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEmcure Pharma
China Registration ClassN/A

Develop Information

Active CompaniesEmcure Pharma
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA09
Related LinksN/A